Archive for the ‘Bartonella’ Category

Rejuvenate Cells & Combat Chronic Illness With a Fasting Mimicking Diet

https://www.treatlyme.net/guide/fasting-mimicking-diet

Rejuvenate Your Cells and Combat Chronic Illness with a Fasting Mimicking Diet

By Dr. Marty Ross

Sept. 2024

If you’re grappling with chronic Lyme disease, Bartonella, Babesia, or mold toxicity, the term “fasting” may seem hard to think about. However, the Fasting Mimicking Diet (FMD) offers a scientifically backed, less intense method that promises significant health benefits. Imagine rejuvenating your injured cells and potentially alleviating symptoms without the extreme measures associated with traditional fasting.

Interested? Let’s explore how FMD may be the game-changer you need.

What is the Fasting Mimicking Diet?

The Fasting Mimicking Diet is a revolutionary dietary protocol that mimics the effects of fasting while still allowing some nutrient intake. Developed by Dr. Valter Longo and his team at the University of Southern California, this diet aims to provide the health benefits of fasting without the hardship of complete food deprivation. It’s a five-day plan that involves reduced calorie intake, typically between 750 to 1,100 calories per day, mainly from plant-based foods, while ensuring that your body enters a fasting-like state.

Understanding Cellular Rejuvenation

Cellular rejuvenation refers to the process of renewing old or damaged cells. This concept is critical for those with chronic illnesses like Lyme disease, Bartonella, Babesia, and mold toxicity, where cellular damage and inflammation from oxidation damage could lead to ongoing symptoms. FMD has been shown to trigger autophagy, a crucial cellular cleanup process where the body removes damaged cells and regenerates new ones. This process not only helps in maintaining cellular health but also stimulates the production of stem cells, which are essential for repairing and regenerating tissues and can help remove senescent zombie cells. By doing so, FMD promotes cellular regeneration and can lead to improved overall health for people living with chronic tick-borne infections and mold toxicity. FMD also potentially enhances longevity and reduces the risk of various age-related diseases.

Key Health Enhancing and Anti-Aging Pathways Affected by the Fasting Mimicking Diet

  • Autophagy Pathway: FMD induces autophagy, a critical process for cellular cleanup and renewal. This promotes the removal of damaged proteins and organelles, supporting longevity and overall health, and may help reduce cellular debris linked to chronic infections like tick-borne diseases and mold toxicity.
  • Cellular Senescence: FMD aids in addressing cellular senescence, where cells lose their ability to divide and function optimally while often developing a pro-inflammatory secretory profile known as the Senescence-Associated Secretory Phenotype (SASP). Chronic infections are a cause of early cellular senescence. By removing these senescent cells and fixing the effects of SASP, the diet may reduce inflammation and tissue damage, contributing to healthier aging, an extended lifespan, and improved health for people with chronic infections and mold-related issues.
  • Improvements in Immune Function: FMD enhances immune function by promoting the regeneration of immune cells and supporting a balanced immune response. This can lead to a more robust defense against infections and a reduction in inflammation, benefiting individuals with chronic illnesses such as tick-borne diseases and mold toxicity. Enhanced immune function contributes to healthier aging and improved resilience against stressors, ensuring better overall health and longevity.
  • mTOR (Mechanistic Target of Rapamycin): FMD reduces signaling through the mTOR pathway, which is closely linked with cell growth, aging, and immune function. Inhibiting mTOR activity can enhance cellular stress resistance, longevity, and may aid in managing chronic infections by improving immune response.
  • IGF-1 (Insulin-like Growth Factor 1): FMD lowers levels of IGF-1, a hormone that promotes growth and has been associated with aging and cancer. Reducing IGF-1 can lead to decreased cellular proliferation and increased autophagy, which may benefit those dealing with persistent infections and inflammation.
  • AMPK (AMP-Activated Protein Kinase): By activating AMPK, the diet enhances energy metabolism and promotes the breakdown of fats. This pathway is associated with improved longevity, protection against age-related diseases, and could also support detoxification and energy balance in individuals facing mold toxicity and chronic infections.
  • Sirtuins Activation: The diet stimulates sirtuins, a family of proteins that regulate cellular health and longevity. Activation of sirtuins is linked to improved DNA repair, enhanced stress resistance, and extended lifespan; these functions may also aid individuals with chronic tick-borne infections and mold toxicity by bolstering cellular resilience and repair mechanisms.  (See link for article)

________________

For more:

Antibiotics vs Herbs: One Doc’s Experience

https://www.treatlyme.net/guide/recovery-crystal-ball-of-odds-and-timelines

In my free Lyme Q&A Webinar called Conversations with Marty Ross MD, people ask me questions related to recovery. Here are some of those questions.

  • Do herbal antibiotics work?
  • Do prescription antibiotics work better than herbal antibiotics?
  • How long will it take me to recover from Bartonella, or Babesia, or Borrelia?
  • Can I recover from chronic Bartonella, Babesia or Borrelia?

Video Article

In the video in the top link, I answer these questions based on my extensive twenty year clinical experience treating persistent tick-borne infections like Lyme, Bartonella, and Babesia using the best herbal and prescription antibiotic approaches. What I discuss is based on my experience. Unfortunately the research answering these questions is very limited or even non-existent.  (See link for article and video)

________________

**Comment**

Please remember, this is simply ONE practitioner’s experience.

Dr. Horowitz recommends treating Babesia for 9 months to a year.  I agree with this and it was our experience.

Regarding Lyme disease, I believe it has more to do with how long you have had it as well as how many other coinfections and comorbidities you have.  The more coinfections and comorbidites – the longer it’s probably going to take – particularly the older you are.  Mold, MCAS, allergies, etc. all play a large role in this a – and are as important as the infection(s).  

For reference, it took FIVE years of treatment followed by 3-4 relapses necessitating treatment before we reached ‘remission.’  Maintaining  the immune system is imperative and that means balancing hormones as well as minerals, vitamins, etc.  I guarantee you WILL NOT get better if you live in a moldy environment or do not deal with these other factors.  

For more:

Florida Undercounts Lyme Disease & Downplays its Risk

https://www.lymedisease.org/florida-undercounts-lyme-disease/

Florida undercounts Lyme disease and downplays its risk

7/8/24

Melissa Bell, President of the Florida Lyme Disease Association, recently met with Florida Surgeon General Joseph A. Ladapo, MD, PhD, to discuss Lyme disease in their state. Their zoom call also included others from the Department of Health as well as Professor Kerry Clark from the University of North Florida.

Here is a follow-up email Melissa sent to the Dr. Ladapo, summarizing the call. This is a highly informative resource for anyone seeking to contact their local and state health officials. We thank Melissa for making this available to our readers.

The evidence is clear that Lyme disease is undercounted in Florida based on various data sources. The CDC surveillance counts place a heavy emphasis on “high incidence” states—which are primarily confined to the Northeast coast and upper Midwest United States. Doctors and patients are falsely told that there is “no Lyme in Florida” or that it is extremely rare.

Melissa Bell, President of Florida Lyme Disease Association.

As a result of this downplaying of the risk of Lyme and other tick-borne infections, people, especially parents, are less likely to take steps to prevent tick bites. Additionally, those infected are less likely to receive an early diagnosis. According to the CDC, “if left untreated, infection can spread to joints, the heart, and the nervous system.”

Due to poor awareness and training, doctors refuse to timely prescribe antibiotics for known tick bites even with symptoms and refuse to test for Lyme because they have been taught there is no Lyme in Florida. There is even less awareness regarding other tick-borne infections that are prevalent in the state, including Babesia, Ehrlichia, Anaplasma, and Bartonella.

Lyme and Bartonella infection can persist for years, despite antibiotic treatment (see studies linked above) and following:

New genetic group/species of Bartonella may be responsible for a portion of Lyme-like illness in Florida and other southern states. Standard lab tests for Bartonella will not likely identify these strains.

  • The CDC shows a 29.44% increase in reported cases in Florida comparing 2017-2019 data to 2022.
  • A 2021 CDC Study analyzing insurance data, revealed that in states the CDC considers to be “low incidence,” only 1 in 50 cases is counted, while in high incidence states 1 in 7 is counted. See also How much does the CDC undercount Lyme cases? It depends on where you live.
  • Standard lab tests for Lyme disease were developed to detect a single Borrelia strain present in the Northeast. Such lab tests fail to detect approximately half of actual cases pursuant to numerous peer reviewed studies. See Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States; see also, Project Lyme. For unknown reasons, it appears as though the Florida Department of Health is not counting most CDC-positive Lyme cases. For example, in a July 2018 report (page 7), Quest Diagnostics showed an increase in Florida Lyme cases from 283 in 2015 to 501 in 2017, representing a 77% increase. In contrast, the CDC only reported 166 Florida Lyme cases in 2015 and 210 in 2017. Why are the CDC’s numbers for Florida so much lower than Quest, a single lab? In recent email correspondence, IGeneX has indicated a 48% positivity rate in Florida for 2023, which they consider high. There were 526 CDC-positive cases through IGeneX in 2023. Note that the IGeneX immunoblot has been validated by New York and other states and is covered by Medicare Part B. We do not have data for labs such as Mayo Clinic, Consolidated, ARUP, Medical Diagnostics Laboratory, Stony Brook University Medical Center, Cleveland Clinic, university and other labs which also test for Lyme disease in Florida, but we trust that the Florida Department of Health has this data available. We would appreciate transparency on these numbers.
  • Canine maps show a significant increase in incidence of Lyme disease, Ehrlichia, and Anaplasma in the state. Notably, dogs are less likely to travel out of state meaning the infections are more often locally acquired. 
    • According to the Companion Animal Parasite Council (CAPC), from 2019 – 2023, canine tick-borne infections have increased by 89.53% for Lyme disease; 100.49% for Ehrlichiosis; and 334.23% for Anaplasmosis in Florida.
    • In 2022, CAPC reported 4,284 canine cases compared to only 233 human cases reported by the CDC.
    • In 2023, CAPC reported 4,888 Lyme disease, 12,601 Ehrlichiosis, and 8,424 Anaplasmosis canine cases.
    • According to 2024 data YTD, Florida is considered moderate risk for Lyme and high risk for both Ehrlichia and Anaplasma. Notably, the Lyme incidence changed from 1/200 in 2023 to 1/100 for 2024 YTD.
    • The CAPC estimates its data represents “less than 30% of the activity in the geographic regions.” Applying this factor to the 4,284 cases in 2022, CAPC would estimate 14,280 canine cases which is >61x the human reported cases for the same year (4,284/.3 = 14,280).
  • MyLymeData statistics for “low incidence” states like Florida likewise show a large disparity between reported and actual cases. See Why Doesn’t the CDC Count Lyme Disease Cases in the South and the West? Everybody Else Does. | LymeDisease.org

The one-size-fits-all IDSA treatment guidelines fail countless patients, particularly those who are not timely diagnosed/treated or present with co-infections such as Babesia, Bartonella, or rickettsial infections.

  • A significant percentage of patients suffer persistent symptoms after antibiotic treatment. The CDC previously estimated 10-20% of patients, but now they claim “following antibiotic treatment, about 5-10% of people with Lyme disease have prolonged symptoms of fatigue, body aches, or difficulty thinking as a result of their infection.” We are unaware of any rationale or scientific basis for this change. To the contrary, research demonstrates a higher percentage. See e.g. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? (at six months, 36% of patients reported new-onset fatigue, 20% widespread pain, and 45% neurocognitive difficulties). It is widely accepted that patients who are not timely diagnosed and treated are more likely to suffer from persistent symptoms after IDSA-recommended treatment.
  • Lyme persists due to biofilms, round bodies, inability of antibiotics to penetrate tissues/organs. See Lyme Persists
  • Studies at Johns Hopkins showed doxycycline failed to eradicate the Lyme bacteria Borrelia burgdorferi in vitro. However, triple antibiotic combinations were effective in a mouse model. See also Superior efficacy of combination antibiotic therapy versus monotherapy in a mouse model of Lyme disease
  • Studies showing “long term antibiotics are not effective” used a single antibiotic, did not have a true placebo (i.e. giving IV rocephin to the control group), and/or ignored improvement of symptoms such as fatigue. Studies were designed to fail and then were widely reported without mention of study limitations/flaws.

The failure to timely diagnose and adequately treat Lyme disease comes at a tremendous economic burden. Lyme patients had 87% more visits to the doctor and 71% more visits to the emergency room within the year following diagnosis. This does not take into account additional economic costs due to missed work and long term disability. See Johns Hopkins study Lyme Disease Costs Up to $1.3 Billion Per Year to Treat, Study Finds and Health Care Costs, Utilization and Patterns of Care following Lyme Disease | PLOS ONE; see also The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic – PMC

Requested Action Items:

  1. Transparency on CDC positive cases. What are the reported case counts for each of the labs who test for Lyme disease in Florida and what percent are being reported to the CDC? Why are such a large percentage of cases not being counted? Why are canine cases an estimated 61x higher than human cases?
  2. Mandated education of clinicians in the state and alerts to medical care providers advising of increase in cases of Lyme, Ehrlichia, and Anaplasma in the state. Babesia and Bartonella can also cause overlapping symptoms. There are free CME webinars available on Invisible International.
  3. Educate residents about the risk of tick bites, including education of children in schools. See e.g. A School-Based Intervention to Increase Lyme Disease Preventive Measures Among Elementary School-Aged Children
  4. Since 2017, Babesia has been reportable in Florida. Please share the reports.
  5. Similar to the federal Tick-Borne Disease Working Group, we request that a Florida task force be formed, composed of members who have a diversity of backgrounds and perspectives (i.e. patients, researchers, health practitioners, public health).
  6. Explore potential legislation in the state promoting tick-borne disease awareness, mandating insurance coverage outside of IDSA guidelines when deemed medically necessary, and protecting doctors who prescribe medications in accordance with the ILADS standard of care. See Reviewing Current Lyme Legislation
  7. Fund research within the state, including widespread tick testing and patient-centered studies (i.e. efficacy of emerging combination therapies, screening of at-risk pregnant women, etc.).
  8. Update Florida Department of Health website on Lyme disease. In particular (but not limited to):
    • The FL DOH page discussing Lyme rashes under the symptoms and treatment tab is outdated and inconsistent with the CDC website. It is critical to communicate that there are many forms of erythema migrans rashes, not just the classic bull’s-eye. The current page states “between 60 and 80% of people will develop a red, “bull’s-eye rash” which is not accurate. In this study, researchers discovered most rashes were uniform in color (51%), pink (74%), oval (63%), and with clear borders (92%). Only 6% had the classic bull’s-eye pattern.
    • Under the symptoms and treatment tab, it states “a few patients, especially those diagnosed in the later stages of disease, may have persistent or recurrent symptoms.” (emphasis added). For many years, the  CDC had recognized that 10-20% of patients continue to suffer symptoms after antibiotic treatment. Without explanation, the CDC recently changed this estimate to 5-10% without any clear rationale for the change. Research from Johns Hopkins demonstrates a higher percentage than the CDC. See e.g. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? (at six months, 36% of patients reported new-onset fatigue, 20% widespread pain, and 45% neurocognitive difficulties); see also Health Care Costs, Utilization and Patterns of Care following Lyme Disease | PLOS ONE (“over 63% of the Lyme disease cases had at least one diagnosis associated with PTLDS, which is 36 percentage points higher a rate than the prevalence of the same symptoms in our control population”). Whatever estimate is used, it is certainly more than “a few.”
    • Under the transmission tab of the FL DOH website, it states “studies have shown that both nymph and adult ticks need to be attached for more than 24 hours to effectively transmit the infection.” However, a literature review has determined that in animal models, transmission can occur in less than 16 hours, and the minimum attachment time for transmission of infection has never been established. See Lyme borreliosis: a review of data on transmission time after tick attachment – PMC. In particular, if a tick is only partially fed and then attaches to a human, spirochetes can be found in the salivary glands increasing the risk of disease transmission after shorter attachment periods. Additionally, if a tick is not removed properly (i.e. if the body is squeezed or if heat or oils are used), then this increases the risk of disease transmission.
    • There is a growing body of research showing that ticks can also spread Bartonella infections to humans. See Can Ticks Transmit Bartonella? – Project Lyme.
    • Include acknowledgement that Lyme can spread from mother to baby during pregnancy. See e.g., CDC “Untreated Lyme disease during pregnancy can lead to infection of the placenta; spread from mother to fetus is possible but extremely rare.” While we disagree with the term “extremely rare” absent scientific studies proving this point, at least the CDC is now publicly acknowledging maternal-fetal transmission. See also Congenital Lyme disease is under-recognized by medical professionals (50% of Lymelight grant recipients were born with Lyme disease); Ongoing study Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure funded by the Clinical Trials Network for Lyme and other Tick-borne Diseases (CTN); Lyme Disease and Pregnancy – LYMEHOPE
    • Provide an acknowledgement that existing laboratory tests for Lyme disease often result in false negative results such as: “if you are tested for Lyme disease and the results are negative, this does not necessarily mean you do not have Lyme disease. If you continue to experience unexplained symptoms, you should contact your health care provider and inquire about the appropriateness of retesting or initial or additional treatment.” See e.g., Maryland legislation.
    • Provide links to both the ILADS and IDSA standards of care for treating Lyme disease and related infections. See Schools of Thought about Lyme Disease

Melissa Bell, Esq. founded the Florida Lyme Disease Association in 2013, after several members of her family were severely impacted by Lyme disease. She also serves on the Executive Board of Project Lyme.

_______________

Great article!  

For more:

The take home: Clark is finding borrelia (Lyme) strains in the South that the current CDC two-tier testing will never pick up in a thousand years.

https://www.researchgate.net/publication/285584725_Isolation_of_live_Borrelia_burgdorferi_sensu_lato_spirochetes_from_patients_with_undefined_disorders_and_symptoms_not_typical_for_Lyme_diseases

The take home: Clark found live Bbsl (bissettii-like strain) in people from the Southeast who had undefined disorders not typical of LD, and were treated for LD even though they were seronegative, proving that B. bissetti is responsible for worldwide human infection.

He also showed DNA of Bbsl in Lone Star ticks which might be a bridge vector of transmission to humans.

Dr. Clark was the first to report finding LD spirochetes in animals and ticks in South Carolina, as well as in wild lizards in South Carolina and Florida. He has documented the presence of LD Borrelia  species, Babesia microti, Anaplasma phagocytophilumRickettsia species, and other tick-borne pathogens in wild animals, ticks, dogs, and humans in Florida and other southern states.

Ross Lyme & Tick-borne Diseases Protocol Version 4

https://www.treatlyme.net/lyme-disease-treatment-guidelines

About The Ross Lyme & Tick-borne Diseases Protocol—Version 4

New in Version 4

The Ross Lyme & Tick-borne Diseases Protocol–Version 4 update, released 6/17/24, has a number of significant changes.

Name change. In Version 4, I have updated our name to include “tick-borne”. This recognizes that people can have Bartonella, Babesia, or other tick-borne diseases, separate from having Lyme (Borrelia) infection.

But there are more significant updates than our name change. Version 4

  • Emphasizes plant-based foods recommendations in Part 2. Diet;
  • Promotes healthy intestinal microbiome—even on antibiotics with a new Part 3. Healthy Intestinal Microbiome; and
  • Includes an herbal antibiotic only option to treat the three Bs (Borrelia, Bartonella, and Babesia) simultaneously in Part 12. Lyme Infection and Part 13. Bartonella & Babesia Infections.
  • Moves lifestyle, and related areas, of sleep, diet, healthy intestinal microbiome, and exercise to the front of the protocol to emphasize the key role these areas have in recovery.

Introduction

These are support and treatment guidelines to treat chronic Lyme or tick-borne infections. This protocol addresses most problems that keep a person from getting well. It is more comprehensive than the antibiotic focused Infectious Disease Society of America (IDSA)International Lyme and Associated Disease Society (ILADS), and United States Centers for Disease Control and Prevention guidelines. While herbal and prescription antibiotics may decrease the germ load in chronic Lyme and tick-borne infections, they often do not correct the underlying problems that cause ongoing symptoms.

The Ross Lyme Support Protocol includes essential steps for the beginning and throughout a chronic Lyme disease or tick-borne infection treatment. It is designed to:

  • boost the immune system,
  • improve detoxification,
  • speed recovery,
  • kill the infections, and
  • protect and repair from the harmful effects of the infections and the herbal or prescription antibiotics.

While the following Lyme disease and tick-borne infection treatment approach focuses on a limited number of areas, it may correct most of the problems like:

  • low energy,
  • pain,
  • insomnia,
  • brain, neurologic, and thinking problems (brain fog), and
  • immune compromise and suppression.

Herxheimer Reactions. When a person starts a Lyme disease or tick-borne infection treatment or changes herbal and prescription antibiotics, it is common to experience some worsening in symptoms. See Herxheimer Die-off Reaction: Inflammation Run Amok for more information about this and the steps you can take to treat it.

Treatment Length and Persistence. Generally, it takes a minimum of six months to see if these supports and treatments will help. Supplements can speed recovery, but treating Lyme still takes time. Once you have marked improvement, then you can likely stop many of these nutritional supports except for probiotics, curcumin, ashwagandha, and a good multivitamin. See Getting Healthy: Will I? When? How Do I? for more information about Lyme disease and tick-borne infection treatment length and persistence.

About Supplements. Throughout this protocol I include supplements as nutritional supports based on their known functions. Basic research and my clinical experience show they may help the various symptoms and problems in Lyme disease and tick-borne infections.  (See link for article)

_______________

**Comment**

Lots of great info here.

For more:

The Mind Blowing Truth About Bartonella: Dr. Ed Breitschwerdt

http://

The Mind Blowing Truth About Bartonella Most Doctors Don’t Know

Dive into the complex world of Bartonella with Dr. Ed Breitschwerdt, a leading veterinary researcher. Unravel the challenges of diagnosing this elusive bacteria, from understanding its diverse transmission vectors to exploring advanced detection methods like digital PCR. Gain insights into the pathophysiology of chronic Bartonella infections and its potential neuropsychiatric manifestations through intriguing case studies. Discover the intricate interplay between acute and chronic phases, antibody production, and the prevalence of different strains that can impact test results. Don’t miss this opportunity to elevate your expertise in managing Bartonella and its intricate implications for human health.

Chapters

00:00 Introduction and Background

00:42 Interest in Bartonella Research

05:38 Challenges and Unique Aspects of Bartonella

08:37 Transmission of Bartonella

11:11 Vectors and Transmission to Humans

14:58 Prevalence of Bartonella and Challenges in Diagnosis

29:35 Chronic Bartonella Infection and Recrudescence

32:20 Pathophysiology of Chronic Bartonella Infection

36:06 Diagnostic Challenges and Digital PCR

41:13 Challenges in Accurate Diagnosis

42:02 Different Results from Different Labs

42:16 Different Isolates of the Organism

43:42 Prevalence of Bartonella Henselae Strains

44:41 Patients Stop Making Antibodies

45:56 Interplay Between Acute and Chronic Infections

46:45 Serofast State in Bartonella Henselae

47:21 Exposure to Bartonella Species

48:19 Testing Blood Donors for Bartonella

49:47 Role of Bartonella in Neurologic Diseases

52:43 Symptoms of Bartonella Infection

54:03 Understanding Bartonella on a Cellular Basis

57:34 Developing a Diagnostic Test for Bartonella

01:00:09 Vaccine Target for Bartonella

01:11:44 Protecting the Human-Animal Bond

01:18:03 Future Goals: Diagnostic Test and Vaccine

Learn more about my guest: Dr. Ed Breitschwerdt, DVM , DACVIM Learn more about Dr. Breitschwerdt and his work at NC State University- https://globalhealth.cvm.ncsu.edu/fac…

Learn more about Dr. Breitschwerdt’s work at Galaxy Diagnostics- https://www.galaxydx.com/

Donate to the NC State Bartonella/Vector Borne Research Fund- https://securelb.imodules.com/s/1209/…

For more: